Semin Liver Dis 2024; 44(02): 191-208
DOI: 10.1055/a-2319-0694
Review Article

Statins in Chronic Liver Disease: Review of the Literature and Future Role

Nguyen Pham
1   Department of Medicine, University of California, Los Angeles, Los Angeles, California
,
Jihane N. Benhammou
1   Department of Medicine, University of California, Los Angeles, Los Angeles, California
2   Veterans Affairs Greater Los Angeles, Los Angeles, California
3   Comprehensive Liver Research Center at University of California, Los Angeles, Los Angeles, California
› Institutsangaben

Funding J.N.B. is supported by the Veterans Affairs Career Development Award IK2CX002593–01A1 and the University of California, Los Angeles Comprehensive Liver Research Center.


Preview

Abstract

Chronic liver disease (CLD) is a major contributor to global mortality, morbidity, and healthcare burden. Progress in pharmacotherapeutic for CLD management is lagging given its impact on the global population. While statins are indicated for the management of dyslipidemia and cardiovascular disease, their role in CLD prevention and treatment is emerging. Beyond their lipid-lowering effects, their liver-related mechanisms of action are multifactorial and include anti-inflammatory, antiproliferative, and immune-protective effects. In this review, we highlight what is known about the clinical benefits of statins in viral and nonviral etiologies of CLD and hepatocellular carcinoma (HCC), and explore key mechanisms and pathways targeted by statins. While their benefits may span the spectrum of CLD and potentially HCC treatment, their role in CLD chemoprevention is likely to have the largest impact. As emerging data suggest that genetic variants may impact their benefits, the role of statins in precision hepatology will need to be further explored.

Supplementary Material



Publikationsverlauf

Accepted Manuscript online:
03. Mai 2024

Artikel online veröffentlicht:
29. Mai 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA